Similar articles

• Pediatric AML: past, present, and future.

  Onel K, Steinherz PG. Onel K, et al. Cancer Invest. 2002;20(7-8):1117. doi: 10.1081/cnv-120005931. Cancer Invest. 2002. PMID: 12449745 No abstract available.
• Progress in the treatment of acute myeloid leukemia.

  Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Ravandi F, et al. Cancer. 2007 Nov 1;110(9):1900-10. doi: 10.1002/cncr.23000. Cancer. 2007. PMID: 17786921 Review.
• Incorporating novel treatment strategies into conventional therapy.

  Estey EH. Estey EH. Clin Adv Hematol Oncol. 2009 Jun;7(6):4-7. Clin Adv Hematol Oncol. 2009. PMID: 19645129 Review. No abstract available.
• Treatment of childhood acute myeloid leukemia.

  ter Bals E, Kaspers GJ. ter Bals E, et al. Expert Rev Anticancer Ther. 2005 Oct;5(5):917-29. doi: 10.1586/14737140.5.5.917. Expert Rev Anticancer Ther. 2005. PMID: 16221060 Review.
• Intensified induction therapy for children with AML.

  Woods WG. Woods WG. Ann Hematol. 2004;83 Suppl 1:S119-20. doi: 10.1007/s00277-004-0850-2. Ann Hematol. 2004. PMID: 15124701 No abstract available.